Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-09 01:12 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2CompletedINTERVENTIONAL

A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin

ClinicalTrials.gov · NCT01975129 · Registry updated: 2015-05-28

Condition / research focus: Vaginal Atrophy
Sponsor: PepTonic Medical AB
Countries with listed sites: Sweden
Registry dates and results: Start: 2013-09. Completion: 2014-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vagitocin (drug) — also listed as: Oxytocin gel 400 International Units

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Women's health clinic
Stockholm, Huddinge, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Neuropeptides and Social Behavior

ClinicalTrials.gov · NCT01680718 · Registry updated: 2015-05-28

Condition / research focus: Social Psychology
Sponsor: University of California, Los Angeles
Countries with listed sites: United States
Registry dates and results: Start: 2012-10. Completion: 2013-09 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug) — also listed as: Syntocinon nasal spray
Intranasal vasopressin (drug)
Intranasal placebo (drug)

Where the study takes place — 1 listed sites

UCLA Department of Psychology
Los Angeles, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Investigating the Effect of Extracellular Calcium on Oxytocin-induced Human Myometrial Contractility In-vitro

ClinicalTrials.gov · NCT02274454 · Registry updated: 2015-05-27

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2014-11. Completion: 2015-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin
Calcium (drug)

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization

ClinicalTrials.gov · NCT02051231 · Registry updated: 2015-05-27

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2013-12. Completion: 2014-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

The Effect of Intranasal Oxytocin on Emphatic Abilities in Patients With Post Traumatic Stress Disorder (PTSD)

ClinicalTrials.gov · NCT01325168 · Registry updated: 2015-05-07

Condition / research focus: Post Traumatic Stress Disorder
Sponsor: Rambam Health Care Campus
Countries with listed sites: Israel
Registry dates and results: Start: 2011-08. Completion: 2013-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

syntocinon nasal spray (drug) — also listed as: nasal oxytocin - 24 IU,
placebo nasal spray (drug) — also listed as: nasal placebo - 24 IU,

Where the study takes place — 2 listed sites

Rambam health care campus
Haifa, Israel
Site recruitment: Not reported
Rambam Medical Center
Haifa, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Gestational Diabetes: Induction Versus Expectant Management of Labour

ClinicalTrials.gov · NCT01058772 · Registry updated: 2015-04-30

Condition / research focus: Gestational Diabetes; Gestational Diabetes Mellitus; Diabetes Mellitus, Gestational; Pregnancy-Induced Diabetes; Diabetes, Pregnancy Induced
Sponsor: IRCCS Burlo Garofolo
Countries with listed sites: Israel · Italy · Netherlands · Slovenia · Sri Lanka
Registry dates and results: Start: 2010-03. Completion: 2014-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

INDUCTION of LABOUR (other)

Where the study takes place — 9 listed sites

Helen Schneider's Hospital for Women - Rabin Medical Center
Petah Tikva, Israel
Site recruitment: Not reported
I Ostetricia Spedali Civili
Brescia, Italy
Site recruitment: Not reported
Department of Gynecology Perinatology and Human Reproduction
Florence, Italy
Site recruitment: Not reported
Unità Operativa di Ostetricia e Ginecologia - Ospedale Buzzi
Milan, Italy
Site recruitment: Not reported
Institute for Maternal and Child Health - IRCCS Burlo Garofolo
Trieste, Italy
Site recruitment: Not reported
Dipartimento di Discipline Ginecologiche ed Ostetriche - Università di Torino
Turin, Italy
Site recruitment: Not reported
Division Woman and Baby - UMC Utrecht/ Wilhelmina Children's Hospital
Utrecht, Netherlands
Site recruitment: Not reported
Department of ob/gyn, Division of perinatology - University Medical Centre
Ljubljana, Slovenia
Site recruitment: Not reported
Department of Obstetrics and Gynecology - University of Colombo
Colombo, Sri Lanka
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Comparative Study on the Effects of Sublingual Misoprostol in Addition to Standard AMTSL in Low Risk Parturients in LASUTH, Ikeja.

ClinicalTrials.gov · NCT02424201 · Registry updated: 2015-04-30

Condition / research focus: Primary Postpartum Haemorrhage
Sponsor: Lagos State University
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-06. Completion: 2016-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Cytotec
vitamin c (drug) — also listed as: ascorbic acid

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section

ClinicalTrials.gov · NCT02101567 · Registry updated: 2015-04-10

Condition / research focus: Bleeding; Anemia
Sponsor: Beni-Suef University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-05. Completion: 2015-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Pabal 100 mcg iv infusion over 1 minute given after delivery of fetal head (drug) — also listed as: Carbetocin
Oxytocin 5 IU iv infusion and Methtergine 0.2 mg iv (drug) — also listed as: Oxytocin and Methyl ergometrine

Where the study takes place — 1 listed sites

Nesreen Abdel Fattah Abdullah Shehata
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Effect of Oxytocin on Gastric Emptying

ClinicalTrials.gov · NCT01152047 · Registry updated: 2015-04-07

Condition / research focus: Dyspepsia; Lack of Satiety
Sponsor: Skane University Hospital
Countries with listed sites: Sweden
Registry dates and results: Start: 2010-05. Completion: 2015-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: syntocinon

Where the study takes place — 1 listed sites

Skåne University Hospital
Malmö, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

The Effect of Oxytocin on the Gastric Emptying

ClinicalTrials.gov · NCT00776360 · Registry updated: 2015-04-07

Condition / research focus: Postprocedural Delayed Gastric Emptying
Sponsor: Skane University Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2008-12. Completion: 2009-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: syntocinon
oxytocin (drug) — also listed as: syntocinon

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage

ClinicalTrials.gov · NCT01863706 · Registry updated: 2015-03-26

Condition / research focus: Post Partum Hemorrhage
Sponsor: Hormozgan University of Medical Sciences
Countries with listed sites: Iran
Registry dates and results: Start: 2013-05. Completion: 2013-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Cytotec
Oxytocin (drug) — also listed as: Syntocinon

Where the study takes place — 1 listed sites

Hormozgan University of Medical Sciences
Bandar Abbas, Hormozgan, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Carbetocin Versus Oxytocin in Caesarean Section for the Control of Postpartum Haemorrhage

ClinicalTrials.gov · NCT02396303 · Registry updated: 2015-03-24

Condition / research focus: Postpartum Haemorrhage
Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Countries with listed sites: Bangladesh
Registry dates and results: Start: 2015-06. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)

Where the study takes place — 1 listed sites

BSMMU
Dhaka, Bangladesh
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Analysis of Contemporary Labor Patterns Measured Via Transperineal Ultrasonography

ClinicalTrials.gov · NCT02393144 · Registry updated: 2015-03-19

Condition / research focus: Pregnancy; Obstetric Labor
Sponsor: Ankara University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2015-02. Completion: 2017-03 (may be estimated). No results posted in this registry response.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Transperineal ultrasonography, General Electric Healthcare Voluson Ultrasound System (device)
Cardiotocography, Bionet FC1400 Fetal Monitor (device)
Amniotomy (other)
Analgesics, Opioid, Meperidine (drug)
Labor augmentation, Oxytocin (drug)
Labor induction, Oxytocin (drug)
Cervical ripening, labor induction, Dinoprostone (drug)

Where the study takes place — 1 listed sites

Ankara University Faculty of Medicine, Department of Obstetrics and Gynecology
Ankara, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Haemodynamic and Cardiovascular Effects of Carbetocin and Oxytocin

ClinicalTrials.gov · NCT01719952 · Registry updated: 2015-02-27

Condition / research focus: Pregnancy Related; Anaesthesia
Sponsor: Universiti Kebangsaan Malaysia Medical Centre
Countries with listed sites: Malaysia
Registry dates and results: Start: 2012-01. Completion: 2014-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin for carbetocin, pitocin for oxytocin
Oxytocin (drug) — also listed as: pitocin

Where the study takes place — 1 listed sites

Department of O&G
Cheras, Kuala Lumpur, Malaysia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Analgesic Effect of Oxytocin Receptor Modulation

ClinicalTrials.gov · NCT01918475 · Registry updated: 2015-02-12

Condition / research focus: Pain; Hyperalgesia; Central Sensitization
Sponsor: Insel Gruppe AG, University Hospital Bern
Countries with listed sites: Switzerland
Registry dates and results: Start: 2013-07. Completion: 2014-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

University Department of Anesthesiology and Pain Therapy, Bern University Hospital
Bern, Canton of Bern, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Effects of Oxytocin on Emotion Recognition and Response Inhibition

ClinicalTrials.gov · NCT02350946 · Registry updated: 2015-01-30

Condition / research focus: The Impact of Oxytocin on Social Cognition
Sponsor: RWTH Aachen University
Countries with listed sites: Germany
Registry dates and results: Start: 2015-01. Completion: 2017-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

University Hospital RWTH Aachen
Aachen, Germany
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

The Effect of 21-Days Intranasal Oxytocin on Patients With Post Traumatic Stress Disorder (PTSD)

ClinicalTrials.gov · NCT02336568 · Registry updated: 2015-01-13

Condition / research focus: PTSD
Sponsor: Rambam Health Care Campus
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-03. Completion: 2018-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytoine (drug) — also listed as: syntocinon nasal spray nasal
PLACEBO (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia

ClinicalTrials.gov · NCT01382732 · Registry updated: 2015-01-05

Condition / research focus: Severe Preeclampsia; Postpartum Hemorrhage
Sponsor: Saint Thomas Hospital, Panama
Countries with listed sites: Panama
Registry dates and results: Start: 2012-01. Completion: 2016-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Lonactene
Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Saint Thomas H
Panama City, Provincia de Panamá, Panama
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effects of MDMA on Social and Emotional Processing

ClinicalTrials.gov · NCT01849419 · Registry updated: 2014-12-18

Condition / research focus: Drug Addiction
Sponsor: University of Chicago
Countries with listed sites: United States
Registry dates and results: Start: 2010-07. Completion: 2013-03 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Within-subjects (MDMA) (drug)
Within-subjects (oxytocin) (drug)
Within-subjects (placebo) (drug)

Where the study takes place — 1 listed sites

University of Chicago
Chicago, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin and Social Cognition

ClinicalTrials.gov · NCT01606462 · Registry updated: 2014-12-03

Condition / research focus: Healthy Male Volunteers
Sponsor: University Hospital, Bonn
Countries with listed sites: Germany
Registry dates and results: Start: 2011-06. Completion: 2013-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Oxytocin: Syntocinon-Spray, Novartis

Where the study takes place — 1 listed sites

Department of Psychiatry, University of Bonn
Bonn, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-09 01:12 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2CompletedINTERVENTIONAL

A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin

ClinicalTrials.gov · NCT01975129 · Registry updated: 2015-05-28

Condition / research focus: Vaginal Atrophy
Sponsor: PepTonic Medical AB
Countries with listed sites: Sweden
Registry dates and results: Start: 2013-09. Completion: 2014-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vagitocin (drug) — also listed as: Oxytocin gel 400 International Units

Where the study takes place — 1 listed sites

Women's health clinic
Stockholm, Huddinge, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Neuropeptides and Social Behavior

ClinicalTrials.gov · NCT01680718 · Registry updated: 2015-05-28

Condition / research focus: Social Psychology
Sponsor: University of California, Los Angeles
Countries with listed sites: United States
Registry dates and results: Start: 2012-10. Completion: 2013-09 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug) — also listed as: Syntocinon nasal spray
Intranasal vasopressin (drug)
Intranasal placebo (drug)

Where the study takes place — 1 listed sites

UCLA Department of Psychology
Los Angeles, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Investigating the Effect of Extracellular Calcium on Oxytocin-induced Human Myometrial Contractility In-vitro

ClinicalTrials.gov · NCT02274454 · Registry updated: 2015-05-27

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2014-11. Completion: 2015-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin
Calcium (drug)

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants After Oxytocin-Induced Desensitization

ClinicalTrials.gov · NCT02051231 · Registry updated: 2015-05-27

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2013-12. Completion: 2014-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

The Effect of Intranasal Oxytocin on Emphatic Abilities in Patients With Post Traumatic Stress Disorder (PTSD)

ClinicalTrials.gov · NCT01325168 · Registry updated: 2015-05-07

Condition / research focus: Post Traumatic Stress Disorder
Sponsor: Rambam Health Care Campus
Countries with listed sites: Israel
Registry dates and results: Start: 2011-08. Completion: 2013-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

syntocinon nasal spray (drug) — also listed as: nasal oxytocin - 24 IU,
placebo nasal spray (drug) — also listed as: nasal placebo - 24 IU,

Where the study takes place — 2 listed sites

Rambam health care campus
Haifa, Israel
Site recruitment: Not reported
Rambam Medical Center
Haifa, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Gestational Diabetes: Induction Versus Expectant Management of Labour

ClinicalTrials.gov · NCT01058772 · Registry updated: 2015-04-30

Condition / research focus: Gestational Diabetes; Gestational Diabetes Mellitus; Diabetes Mellitus, Gestational; Pregnancy-Induced Diabetes; Diabetes, Pregnancy Induced
Sponsor: IRCCS Burlo Garofolo
Countries with listed sites: Israel · Italy · Netherlands · Slovenia · Sri Lanka
Registry dates and results: Start: 2010-03. Completion: 2014-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

INDUCTION of LABOUR (other)

Where the study takes place — 9 listed sites

Helen Schneider's Hospital for Women - Rabin Medical Center
Petah Tikva, Israel
Site recruitment: Not reported
I Ostetricia Spedali Civili
Brescia, Italy
Site recruitment: Not reported
Department of Gynecology Perinatology and Human Reproduction
Florence, Italy
Site recruitment: Not reported
Unità Operativa di Ostetricia e Ginecologia - Ospedale Buzzi
Milan, Italy
Site recruitment: Not reported
Institute for Maternal and Child Health - IRCCS Burlo Garofolo
Trieste, Italy
Site recruitment: Not reported
Dipartimento di Discipline Ginecologiche ed Ostetriche - Università di Torino
Turin, Italy
Site recruitment: Not reported
Division Woman and Baby - UMC Utrecht/ Wilhelmina Children's Hospital
Utrecht, Netherlands
Site recruitment: Not reported
Department of ob/gyn, Division of perinatology - University Medical Centre
Ljubljana, Slovenia
Site recruitment: Not reported
Department of Obstetrics and Gynecology - University of Colombo
Colombo, Sri Lanka
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Comparative Study on the Effects of Sublingual Misoprostol in Addition to Standard AMTSL in Low Risk Parturients in LASUTH, Ikeja.

ClinicalTrials.gov · NCT02424201 · Registry updated: 2015-04-30

Condition / research focus: Primary Postpartum Haemorrhage
Sponsor: Lagos State University
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-06. Completion: 2016-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Cytotec
vitamin c (drug) — also listed as: ascorbic acid

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section

ClinicalTrials.gov · NCT02101567 · Registry updated: 2015-04-10

Condition / research focus: Bleeding; Anemia
Sponsor: Beni-Suef University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-05. Completion: 2015-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Pabal 100 mcg iv infusion over 1 minute given after delivery of fetal head (drug) — also listed as: Carbetocin
Oxytocin 5 IU iv infusion and Methtergine 0.2 mg iv (drug) — also listed as: Oxytocin and Methyl ergometrine

Where the study takes place — 1 listed sites

Nesreen Abdel Fattah Abdullah Shehata
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Effect of Oxytocin on Gastric Emptying

ClinicalTrials.gov · NCT01152047 · Registry updated: 2015-04-07

Condition / research focus: Dyspepsia; Lack of Satiety
Sponsor: Skane University Hospital
Countries with listed sites: Sweden
Registry dates and results: Start: 2010-05. Completion: 2015-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: syntocinon

Where the study takes place — 1 listed sites

Skåne University Hospital
Malmö, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

The Effect of Oxytocin on the Gastric Emptying

ClinicalTrials.gov · NCT00776360 · Registry updated: 2015-04-07

Condition / research focus: Postprocedural Delayed Gastric Emptying
Sponsor: Skane University Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2008-12. Completion: 2009-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: syntocinon
oxytocin (drug) — also listed as: syntocinon

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage

ClinicalTrials.gov · NCT01863706 · Registry updated: 2015-03-26

Condition / research focus: Post Partum Hemorrhage
Sponsor: Hormozgan University of Medical Sciences
Countries with listed sites: Iran
Registry dates and results: Start: 2013-05. Completion: 2013-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Cytotec
Oxytocin (drug) — also listed as: Syntocinon

Where the study takes place — 1 listed sites

Hormozgan University of Medical Sciences
Bandar Abbas, Hormozgan, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Carbetocin Versus Oxytocin in Caesarean Section for the Control of Postpartum Haemorrhage

ClinicalTrials.gov · NCT02396303 · Registry updated: 2015-03-24

Condition / research focus: Postpartum Haemorrhage
Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Countries with listed sites: Bangladesh
Registry dates and results: Start: 2015-06. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)

Where the study takes place — 1 listed sites

BSMMU
Dhaka, Bangladesh
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Analysis of Contemporary Labor Patterns Measured Via Transperineal Ultrasonography

ClinicalTrials.gov · NCT02393144 · Registry updated: 2015-03-19

Condition / research focus: Pregnancy; Obstetric Labor
Sponsor: Ankara University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2015-02. Completion: 2017-03 (may be estimated). No results posted in this registry response.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Transperineal ultrasonography, General Electric Healthcare Voluson Ultrasound System (device)
Cardiotocography, Bionet FC1400 Fetal Monitor (device)
Amniotomy (other)
Analgesics, Opioid, Meperidine (drug)
Labor augmentation, Oxytocin (drug)
Labor induction, Oxytocin (drug)
Cervical ripening, labor induction, Dinoprostone (drug)

Where the study takes place — 1 listed sites

Ankara University Faculty of Medicine, Department of Obstetrics and Gynecology
Ankara, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Haemodynamic and Cardiovascular Effects of Carbetocin and Oxytocin

ClinicalTrials.gov · NCT01719952 · Registry updated: 2015-02-27

Condition / research focus: Pregnancy Related; Anaesthesia
Sponsor: Universiti Kebangsaan Malaysia Medical Centre
Countries with listed sites: Malaysia
Registry dates and results: Start: 2012-01. Completion: 2014-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin for carbetocin, pitocin for oxytocin
Oxytocin (drug) — also listed as: pitocin

Where the study takes place — 1 listed sites

Department of O&G
Cheras, Kuala Lumpur, Malaysia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Analgesic Effect of Oxytocin Receptor Modulation

ClinicalTrials.gov · NCT01918475 · Registry updated: 2015-02-12

Condition / research focus: Pain; Hyperalgesia; Central Sensitization
Sponsor: Insel Gruppe AG, University Hospital Bern
Countries with listed sites: Switzerland
Registry dates and results: Start: 2013-07. Completion: 2014-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

University Department of Anesthesiology and Pain Therapy, Bern University Hospital
Bern, Canton of Bern, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Effects of Oxytocin on Emotion Recognition and Response Inhibition

ClinicalTrials.gov · NCT02350946 · Registry updated: 2015-01-30

Condition / research focus: The Impact of Oxytocin on Social Cognition
Sponsor: RWTH Aachen University
Countries with listed sites: Germany
Registry dates and results: Start: 2015-01. Completion: 2017-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

University Hospital RWTH Aachen
Aachen, Germany
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

The Effect of 21-Days Intranasal Oxytocin on Patients With Post Traumatic Stress Disorder (PTSD)

ClinicalTrials.gov · NCT02336568 · Registry updated: 2015-01-13

Condition / research focus: PTSD
Sponsor: Rambam Health Care Campus
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-03. Completion: 2018-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytoine (drug) — also listed as: syntocinon nasal spray nasal
PLACEBO (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia

ClinicalTrials.gov · NCT01382732 · Registry updated: 2015-01-05

Condition / research focus: Severe Preeclampsia; Postpartum Hemorrhage
Sponsor: Saint Thomas Hospital, Panama
Countries with listed sites: Panama
Registry dates and results: Start: 2012-01. Completion: 2016-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Lonactene
Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Saint Thomas H
Panama City, Provincia de Panamá, Panama
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effects of MDMA on Social and Emotional Processing

ClinicalTrials.gov · NCT01849419 · Registry updated: 2014-12-18

Condition / research focus: Drug Addiction
Sponsor: University of Chicago
Countries with listed sites: United States
Registry dates and results: Start: 2010-07. Completion: 2013-03 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Within-subjects (MDMA) (drug)
Within-subjects (oxytocin) (drug)
Within-subjects (placebo) (drug)

Where the study takes place — 1 listed sites

University of Chicago
Chicago, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin and Social Cognition

ClinicalTrials.gov · NCT01606462 · Registry updated: 2014-12-03

Condition / research focus: Healthy Male Volunteers
Sponsor: University Hospital, Bonn
Countries with listed sites: Germany
Registry dates and results: Start: 2011-06. Completion: 2013-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Oxytocin: Syntocinon-Spray, Novartis

Where the study takes place — 1 listed sites

Department of Psychiatry, University of Bonn
Bonn, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →